Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey

IF 3.6 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Alexandre Campeau Calfat, Béatrice Martin, Caroline Sirois
{"title":"Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey","authors":"Alexandre Campeau Calfat,&nbsp;Béatrice Martin,&nbsp;Caroline Sirois","doi":"10.1111/bcpt.70328","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Community pharmacists in Quebec can bill for deprescribing. However, uptake remains low. We aimed to explore how community pharmacists perceive and engage in deprescribing.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Community pharmacists were invited to complete an online survey through a pharmacists' social media group and a newsletter. Data were analysed using descriptive statistics and univariate chi-square tests.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 366 respondents, most were women (<i>n</i> = 269; 74%), worked full-time (<i>n</i> = 282; 77%), had time for clinical interventions (<i>n</i> = 223; 61%), while 53% (<i>n</i> = 193) had fewer than 11 years of experience. Three quarters (<i>n</i> = 271) reported initiating deprescribing at least monthly. Side effects (<i>n</i> = 273; 75%) and patients' requests (<i>n</i> = 220; 60%) were more common reasons for deprescribing. More than 70% (<i>n</i> = 268) reported that prescribers usually accepted recommendations. Initial and follow-up consultations were systematically billed by 50% (<i>n</i> = 183) and 48% (<i>n</i> = 174) of respondents, respectively. Deprescribing interventions and billing practices were more common among pharmacists with dedicated clinical time and those working full time (all <i>p</i> &lt; 0.01). Main barriers to billing were insufficient training (<i>n</i> = 217; 59%), uncertainty about reimbursement eligibility (<i>n</i> = 127; 35%) and lack of time (<i>n</i> = 112; 31%). Integrated software was the most common facilitator (<i>n</i> = 246; 67%).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Deprescribing was commonly reported among respondents and was often prompted by clinical concerns and patient requests. Billing uncertainties and time constraints remained important barriers, highlighting opportunities to better support deprescribing in community pharmacy.</p>\n </section>\n </div>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"139 6","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.70328","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70328","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Community pharmacists in Quebec can bill for deprescribing. However, uptake remains low. We aimed to explore how community pharmacists perceive and engage in deprescribing.

Methods

Community pharmacists were invited to complete an online survey through a pharmacists' social media group and a newsletter. Data were analysed using descriptive statistics and univariate chi-square tests.

Results

Among 366 respondents, most were women (n = 269; 74%), worked full-time (n = 282; 77%), had time for clinical interventions (n = 223; 61%), while 53% (n = 193) had fewer than 11 years of experience. Three quarters (n = 271) reported initiating deprescribing at least monthly. Side effects (n = 273; 75%) and patients' requests (n = 220; 60%) were more common reasons for deprescribing. More than 70% (n = 268) reported that prescribers usually accepted recommendations. Initial and follow-up consultations were systematically billed by 50% (n = 183) and 48% (n = 174) of respondents, respectively. Deprescribing interventions and billing practices were more common among pharmacists with dedicated clinical time and those working full time (all p < 0.01). Main barriers to billing were insufficient training (n = 217; 59%), uncertainty about reimbursement eligibility (n = 127; 35%) and lack of time (n = 112; 31%). Integrated software was the most common facilitator (n = 246; 67%).

Conclusion

Deprescribing was commonly reported among respondents and was often prompted by clinical concerns and patient requests. Billing uncertainties and time constraints remained important barriers, highlighting opportunities to better support deprescribing in community pharmacy.

Abstract Image

加拿大魁省社区药师对处方减量的看法与经验:一项调查结果。
背景:魁北克的社区药剂师可以为处方开具账单。然而,吸收率仍然很低。我们的目的是探索社区药剂师如何感知和参与处方。方法:邀请社区药剂师通过药剂师社交媒体群和通讯完成在线调查。数据分析采用描述性统计和单变量卡方检验。结果:在366名受访者中,大多数是女性(n = 269; 74%),全职工作(n = 282; 77%),有时间进行临床干预(n = 223; 61%),而53% (n = 193)的经验不足11年。四分之三(n = 271)报告至少每月开始处方。副作用(n = 273; 75%)和患者要求(n = 220; 60%)是更常见的处方解除原因。超过70% (n = 268)的人报告开处方者通常接受建议。最初和后续咨询分别由50% (n = 183)和48% (n = 174)的受访者系统计费。减少处方干预和计费行为在专职临床时间和全职工作的药师中更为常见(p结论:受访者普遍报告减少处方,并且通常是由临床问题和患者要求引起的。账单的不确定性和时间限制仍然是重要的障碍,突出了更好地支持社区药房处方的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书